Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Biology is pushing open the door to germline gene therapies that one day might eradicate disease genes not only from the sufferers but also from their descendants. Now society must decide whether to pursue these therapies.
Recent publication of the results of the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial has led to the Woman's Health Initiative(WHI) to rethink the protocols for its own large trial.
It is unclear whether modified immunoglobulins are at least partially responsible for rheumatoid arthritis (pages 237–243) or only an effect of the disease.